ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Recurrence
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Orlando, FL, USA:

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Orlando, Florida, United States and 37 other locations

in participants with relapsed or refractory aggressive B-cell Non-Hodgkin's lymphoma. The study utilizes an optimized ster...

Enrolling
B-Cell Non-Hodgkins Lymphoma
Drug: Glofitamab
Drug: Gemcitabine

Phase 2

Roche
Roche

Orlando, Florida, United States and 51 other locations

CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma...

Enrolling
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma Refractory
Biological: axicabtagene ciloleucel
Biological: lisocabtagene maraleucel

Phase 3

Lyell Immunopharma

Orlando, Florida, United States and 38 other locations

This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in...

Enrolling
Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Drug: Isatuximab
Drug: Mesna

Phase 1, Phase 2

Indapta Therapeutics

Lake Mary, Florida, United States and 11 other locations

20-expressing Non-Hodgkin lymphoma....

Enrolling
Primary Mediastinal Large B Cell Lymphoma
Marginal Zone Lymphoma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 1

Acepodia Biotech

Orlando, Florida, United States and 12 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Lake Mary, Florida, United States and 71 other locations

doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects ≤75 years of age with previously untreated non-germinal....

Active, not recruiting
Diffuse Large B-Cell Lymphoma
Drug: Cyclophosphamide
Drug: Rituximab

Phase 3

Acerta Pharma
Acerta Pharma

Orlando, Florida, United States and 242 other locations

Locations recently updated

Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...

Enrolling
Follicular Lymphoma (FL)
Drug: Obinutuzumab
Drug: Doxorubicin

Phase 3

Genmab
Genmab

Orlando, Florida, United States and 265 other locations

by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...

Active, not recruiting
Hodgkin Lymphoma
Non Small Cell Lung Cancer
Combination Product: Fruquintinib
Drug: IMT-009

Phase 1, Phase 2

Immunitas Therapeutics

Orlando, Florida, United States and 8 other locations

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling
Lymphoma, Non-Hodgkin
Multiple Myeloma
Drug: Trastuzumab and Pertuzumab
Drug: Fam-Trastuzumab Deruxtecan-Nxki (TDxD)

Phase 2

American Society of Clinical Oncology

Orlando, Florida, United States and 173 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems